French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

Press releases published on July 2, 2026

Jul. 2, 2026

Top 10 China Orthopedic Trauma Implant Manufacturers for the Turkish Market

Indeterminate EIN Presswire

Jul. 2, 2026

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

GuideAI Health Corp. Engages Market Maker

Indeterminate GlobeNewswire

Jul. 2, 2026

Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.

Indeterminate GlobeNewswire

Jul. 2, 2026

Mobia Medical Announces Vivistim® Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule

Indeterminate GlobeNewswire

Jul. 2, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026

Indeterminate GlobeNewswire

Jul. 2, 2026

CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors

Indeterminate GlobeNewswire

Jul. 2, 2026

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Jul. 2, 2026

Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire